Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RIGL

Rigel Pharmaceuticals

Feb 06 • 04:00PM ET

34.15

+0.93 2.80 %

Healthcare • Biotechnology • USA • NASD

Peers: GILD INCY NVAX VKTX ARWR ACAD ENTA KURA AMRN ANAB

| Held by: XBI VTI IWM AVUV VXF IWO IBB VTWO SCHA CALF

Scroll to Statements

Index	RUT	P/E	5.54	EPS (ttm)	6.17	Insider Own	2.61%	Shs Outstand	18.14M	Perf Week	-2.04%
Market Cap	619.87M	Forward P/E	8.60	EPS next Y	3.97	Insider Trans	0.00%	Shs Float	17.68M	Perf Month	-27.39%
Enterprise Value	543.61M	PEG	0.13	EPS next Q	1.20	Inst Own	83.60%	Short Float	20.94%	Perf Quarter	-9.78%
Income	113.30M	P/S	2.20	EPS this Y	570.54%	Inst Trans	5.21%	Short Ratio	6.81	Perf Half Y	12.19%
Sales	282.08M	P/B	5.27	EPS next Y	-40.19%	ROA	59.33%	Short Interest	3.70M	Perf YTD	-20.27%
Book/sh	6.48	P/C	4.52	EPS next 5Y	67.79%	ROE	220.06%	52W High	52.24 -34.63%	Perf Year	49.52%
Cash/sh	7.56	P/FCF	9.10	EPS past 3/5Y	- -	ROIC	76.48%	52W Low	15.50 120.32%	Perf 3Y	98.55%
Dividend Est.	-	EV/EBITDA	4.48	Sales past 3/5Y	6.30% 24.77%	Gross Margin	93.10%	Volatility	5.25% 5.34%	Perf 5Y	-9.66%
Dividend TTM	-	EV/Sales	1.93	EPS Y/Y TTM	2798.12%	Oper. Margin	42.17%	ATR (14)	1.99	Perf 10Y	24.18%
Dividend Ex-Date	-	Quick Ratio	2.14	Sales Y/Y TTM	79.13%	Profit Margin	40.17%	RSI (14)	37.21	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	2.28	EPS Q/Q	106.95%	SMA20	-7.21%	Beta	1.11	Target Price	51.60
Payout	0.00%	Debt/Eq	0.52	Sales Q/Q	25.59%	SMA50	-17.32%	Rel Volume	0.65	Prev Close	33.22
Employees	164	LT Debt/Eq	0.26	Earnings	Nov 04 AMC	SMA200	10.16%	Avg Volume	543.24K	Price	34.15
IPO	Nov 29, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	62.28% 12.25%	Trades		Volume	353,840	Change	2.80%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-05-25	Upgrade	Jefferies	Hold → Buy	$42
Apr-03-23	Resumed	Piper Sandler	Neutral	$2
Jun-09-22	Downgrade	Citigroup	Buy → Neutral
Jun-08-22	Downgrade	Piper Sandler	Overweight → Neutral	$7 → $1
Jun-08-22	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$6 → $1
Mar-23-22	Initiated	B. Riley Securities	Neutral	$4
Nov-09-20	Downgrade	JP Morgan	Overweight → Neutral
Nov-15-19	Resumed	Cantor Fitzgerald	Overweight	$7 → $5
Sep-26-19	Resumed	JP Morgan	Overweight	$7
Mar-01-19	Reiterated	Cantor Fitzgerald	Overweight	$9 → $7
Aug-27-18	Initiated	Citigroup	Buy	$8.50
May-02-18	Reiterated	Cantor Fitzgerald	Overweight	$6 → $9
Dec-21-17	Resumed	Piper Jaffray	Overweight	$6
Dec-15-17	Initiated	Cantor Fitzgerald	Overweight	$6
Nov-06-17	Resumed	H.C. Wainwright	Buy	$7
Mar-09-17	Reiterated	H.C. Wainwright	Buy	$6 → $5
Aug-31-16	Reiterated	H.C. Wainwright	Buy	$6 → $7
Aug-30-16	Reiterated	Piper Jaffray	Overweight	$10 → $11
Jul-13-16	Initiated	H.C. Wainwright	Buy	$6
Jun-13-16	Initiated	Piper Jaffray	Overweight

Show Previous Ratings

Feb-03-26 08:05AM	Rigel Appoints Michael P. Miller to the Board of Directors (PR Newswire)
Jan-28-26 11:24AM	FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside? (Zacks) -5.37%
Jan-16-26 10:26AM	Rigel Pharmaceuticals, Inc. (RIGL) Releases Preliminary Results for Q4 2025 (Insider Monkey)
08:55AM	Profound Medical (PROF) Soars 9.5%: Is Further Upside Left in the Stock? (Zacks)
Jan-12-26 08:05AM	Rigel Provides Business Update and 2026 Outlook (PR Newswire)
08:05AM	Loading…
Jan-09-26 08:05AM	Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) -8.22%
Jan-08-26 12:21PM	CNC Deepens Medicaid Strategy With Cityblock Partnership in Illinois (Zacks) -5.38%
09:36AM	Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics (Zacks)
Jan-07-26 12:31PM	Select Medical Expands Rehab Footprint Through Vibra Healthcare JV (Zacks) +8.66%
08:45AM	5 Small Drug Stocks to Buy as Industry Recovery Picks Up (Zacks)
08:05AM	Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-06-26 10:00AM	Best Momentum Stocks to Buy for January 6th (Zacks) +5.07%
05:33AM	New Strong Buy Stocks for January 6th (Zacks)
Dec-07-25 09:30AM	Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition (PR Newswire)
Dec-05-25 12:00PM	Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? (Zacks)
04:00PM	Loading…
Dec-03-25 04:00PM	AppLovin Stock Rides Swarm Of Setups Beyond Just Mining, Medical Names (Investor's Business Daily) +6.30%
09:40AM	Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? (Zacks)
Nov-27-25 09:15AM	Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-26-25 08:05AM	Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference (PR Newswire)
Nov-17-25 01:38PM	Eli Lilly Partner And Cancer Treatment Maker Nears Buy Point (Investor's Business Daily)
08:05AM	Rigel Announces Publication of Final 5-year Data on REZLIDHIA (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology (PR Newswire)
Nov-12-25 08:05AM	Rigel to Present at the Jefferies Global Healthcare Conference in London (PR Newswire) +5.24%
Nov-06-25 12:20PM	Surging Earnings Estimates Signal Upside for Rigel (RIGL) Stock (Zacks)
12:00PM	All You Need to Know About Rigel (RIGL) Rating Upgrade to Strong Buy (Zacks)
Nov-05-25 12:01AM	Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Call Highlights: Record Revenue and Raised ... (GuruFocus.com) +33.37%
Nov-04-25 05:25PM	Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates (Zacks) -7.41%
04:22PM	Rigel: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update (PR Newswire)
Nov-03-25 09:05AM	Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition (PR Newswire)
07:57AM	Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
01:53PM	Loading…
Oct-31-25 01:53PM	Rigel Gears Up to Report Q3 Earnings: Here's What to Expect (Zacks)
Oct-29-25 08:05AM	Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update (PR Newswire)
Oct-15-25 09:40AM	Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now? (Zacks)
Oct-14-25 09:35AM	After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Rigel (RIGL) (Zacks)
Oct-08-25 08:05AM	Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS (PR Newswire)
Oct-03-25 08:05AM	Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Sep-29-25 07:09PM	Voya Strengthens Position in Rigel Pharmaceuticals, Inc. (RIGL) (Insider Monkey)
10:04AM	Can RIGL's Oncology Portfolio Create Long-Term Value Beyond Tavalisse? (Zacks)
09:40AM	Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? (Zacks)
Sep-26-25 09:35AM	Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Sep-25-25 11:26AM	RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential? (Zacks) -5.22%
Sep-18-25 11:25AM	Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? (Zacks)
Sep-17-25 02:27PM	What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)? (Insider Monkey)
Sep-11-25 09:48AM	Can Tavalisse Drive Rigel's Growth Through the Rest of 2025? (Zacks)
Sep-09-25 12:00PM	What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now? (Zacks) -12.09%
Sep-08-25 02:45PM	Dianthus Therapeutics Stock Earns RS Rating Upgrade (Investor's Business Daily)
Sep-05-25 09:09AM	Do Options Traders Know Something About RIGL Stock We Don't? (Zacks)
Sep-03-25 02:02PM	PTC Therapeutics Stock Sees RS Rating Improve To 77 (Investor's Business Daily)
Aug-27-25 01:57PM	KalVista Pharmaceuticals Stock Sees RS Rating Rise To 82 (Investor's Business Daily)
Aug-26-25 08:05AM	Rigel to Participate in Upcoming September Investor Conferences (PR Newswire)
Aug-25-25 02:03PM	Corcept Shares Rise 39.6% in YTD: How Should You Play the Stock? (Zacks)
10:15AM	This Darling Pharma Stock Is Hitting New Highs, But the Momentum Could Run Out Soon (Barchart)
09:15AM	Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out? (Zacks)
Aug-22-25 09:04AM	Target Stock Market Leaders Rising In Heavy Volume With This Powerful Screen (Investor's Business Daily)
Aug-20-25 12:45PM	Madrigal Gets Conditional Nod for MASH Drug Rezdiffra in EU (Zacks) +6.21%
Aug-15-25 09:50AM	SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease (Zacks)
Aug-12-25 09:15AM	Xeris Biopharma Holdings, Inc. (XERS) Hits Fresh High: Is There Still Room to Run? (Zacks)
09:11AM	H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT (Insider Monkey)
Aug-08-25 12:20PM	Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy? (Zacks)
10:00AM	Best Momentum Stock to Buy for August 8th (Zacks)
09:15AM	5 Best Stocks With Relative Price Strength to Buy Right Now (Zacks)
06:09AM	New Strong Buy Stocks for August 8th (Zacks)
Aug-07-25 02:00PM	Supernus Pharmaceuticals Stock Scores RS Rating Upgrade (Investor's Business Daily)
09:55AM	Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
09:15AM	Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? (Zacks)
Aug-06-25 03:29AM	Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... (GuruFocus.com) +22.98%
Aug-05-25 06:10PM	Rigel Pharmaceuticals (RIGL) Q2 Earnings and Revenues Surpass Estimates (Zacks) +6.93%
05:04PM	Rigel: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update (PR Newswire)
Aug-04-25 10:00AM	Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Jul-31-25 10:00AM	Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards? (Zacks)
Jul-30-25 12:10PM	Why Rigel (RIGL) Could Beat Earnings Estimates Again (Zacks) +5.58%
09:55AM	Can Rigel (RIGL) Climb 69.55% to Reach the Level Wall Street Analysts Expect? (Zacks)
09:40AM	Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now? (Zacks)
Jul-29-25 08:05AM	Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update (PR Newswire)
Jul-10-25 11:14AM	H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL) (Insider Monkey)
Jul-07-25 08:05AM	Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
May-29-25 09:40AM	Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? (Zacks)
May-28-25 09:55AM	Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? (Zacks)
08:05AM	Rigel to Present at the Jefferies Global Healthcare Conference (PR Newswire)
May-22-25 05:20PM	Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress (PR Newswire) -5.78%
May-14-25 09:55AM	Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now (Zacks)
May-13-25 09:40AM	Is Rigel Pharmaceuticals (RIGL) a Great Value Stock Right Now? (Zacks)
May-10-25 11:55AM	Biotech Alert: Searches spiking for these stocks today (TipRanks)
May-09-25 12:20PM	Earnings Estimates Rising for Rigel (RIGL): Will It Gain? (Zacks)
May-08-25 09:55AM	Wall Street Analysts Think Rigel (RIGL) Could Surge 82.3%: Read This Before Placing a Bet (Zacks)
May-07-25 06:16PM	Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum (Seeking Alpha)
03:18AM	Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-06-25 11:13PM	Rigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:30PM	Rigel Pharmaceuticals (RIGL) Beats Q1 Earnings and Revenue Estimates (Zacks)
04:01PM	Rigel Reports First Quarter 2025 Financial Results and Provides Business Update (PR Newswire)
May-05-25 10:14AM	Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
May-01-25 05:35PM	Ardelyx (ARDX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
Apr-29-25 08:05AM	Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update (PR Newswire)
Apr-24-25 07:05AM	Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-17-25 12:00PM	Rigel (RIGL) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
08:21AM	4 Healthcare Stocks to Buy as the Sector Faces Government Heat (Zacks)
Apr-04-25 03:31PM	Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability (Seeking Alpha)
08:05AM	Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Mar-27-25 08:05AM	Rigel Announces Settlement Agreement Resolving TAVALISSE (fostamatinib disodium hexahydrate) Patent Litigation (PR Newswire)

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RODRIGUEZ RAUL R	CEO, President	Jan 26 '26	Option Exercise	27.40	80,000	2,192,000	285,243	Feb 04 04:20 PM
Schorno Dean L	EVP & Chief Financial Officer	Dec 22 '25	Option Exercise	21.51	6,500	139,786	64,235	Dec 29 08:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RIGL

Rigel Pharmaceuticals

Upgrade your FINVIZ experience